GGrantIndex
Sort

261,768 grants matching gene therapy

Mechanisms of Pancreas Development

$1,482,128
Mark A Magnuson · Vanderbilt University · U19 · FY2008 · DK

Mechanisms of Pancreas Development

$1,482,126
Mark A Magnuson · Vanderbilt University · U19 · FY2007 · DK

Therapeutic Strategy for LAM (Lymphangioleiomyomatosis)

$1,482,013
Tony Eissa · Baylor College Of Medicine · UH3 · FY2016 · TR

Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery

$1,482,000
Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2021 · DK

Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways

$1,481,400
Matthew D Disney · Scripps Florida · P01 · FY2017 · NS

Translational Immunology research: a support for clinical immunological research

$1,481,347
Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2019 · AR

CD8+ T cells and Immunological Tumor Regression

$1,481,141
Hans Schreiber · University Of Chicago · P01 · FY2012 · CA

Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapies

$1,481,031
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies

$1,481,031
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

GENE THERAPY FOR CYSTIC FIBROSIS LUNG DISEASE

$1,481,025
University Of Iowa · P01 · FY2003 · HL

Novel drug VS-105 for treatment of osteoporosis

$1,480,983
Jinshyun Ruth Wu-Wong · Vidasym, Inc. · R44 · FY2016 · AR

The Biology of Prostate Cancer Skeletal Metastases

$1,480,775
Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2023 · CA

The Biology of Prostate Cancer Skeletal Metastases

$1,480,743
Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2021 · CA

Molecular Biology Of Outer Retina-specific Proteins

$1,480,677
Thomas Redmond · National Eye Institute · ZIA · FY2017 · EY

Anatomic Pathology Residency Program

$1,480,669
Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2016 · CA

Base-Editing the Cancer Kinome to Enable Drug Discovery

$1,480,500
Neil Vasan · Columbia University Health Sciences · DP2 · FY2023 · CA

SPATIALLY MAPPING OF POOLED IN VIVO CRISPR SCREENS IN THE TUMOR MICROENVIRONMENT

$1,480,500
Jellert Gaublomme · Columbia Univ New York Morningside · DP2 · FY2022 · CA

RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection

$1,480,332
Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2019 · AI

Activities Of Chemokines In Health and Disease

$1,480,285
Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Tolerability of SRX246 in Huntington's Disease Patients

$1,480,173
Michael J Brownstein · Azevan Pharmaceuticals, Inc. · U44 · FY2017 · NS

Clinical Investigations of Sjogren's Syndrome

$1,480,118
Gabor Illei · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE

Chemokines in Skin Immune Cell Trafficking & Cancer Progression

$1,480,101
Sam Hwang · Clinical Sciences · Z01 · FY2007 · CA

Investigations of Methylmalonic Acidemia and Related Disorders

$1,480,072
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2012 · HG

Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS

$1,480,058
Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2017 · DA

Dysregulation of metabolic and bioenergetic pathways by cocaine and HIV-1 in CNS

$1,480,058
Kamel Khalili · Temple Univ Of The Commonwealth · P01 · FY2019 · DA